Clinical Trials Logo

Clinical Trial Summary

Subjects were randomly assigned to groups for treatment with either an EGF-containing ointment (the study group) or the vehicle alone (petrolatum; the control group). The EGF ointment included recombinant human EGF (1 μg/g). Random numbers used for assignment to groups were provided by the randomization function of SAS. The subjects received one session of laser treatment with a Q-switched (QS) 532-nm Nd:yttrium aluminum garnet (YAG) laser of their solar lentigines after enrollment. . The end point of laser treatment for lentigines was immediate whitening. The subjects then applied the EGF ointment or vehicle twice daily (morning and evening) to the lesion for 4 weeks after laser treatment.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04704245
Study type Interventional
Source Hallym University Kangnam Sacred Heart Hospital
Contact
Status Completed
Phase N/A
Start date July 20, 2017
Completion date December 26, 2018

See also
  Status Clinical Trial Phase
Completed NCT04586816 - Randomized, Double-Blind Evaluation of Maple Leaf Extract (Maplifa) for Photoaging N/A
Completed NCT06000839 - A Safety and Effectiveness Study of CELLBOOSTER® Lift (Stabilized Booster Complex Using CHAC Technology) N/A
Completed NCT02138539 - Evaluation of an Herbal-Based De-Pigmenting System Phase 4
Recruiting NCT05362929 - Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color N/A
Completed NCT06031116 - Efficacy of Ceramic Soft Tissue Trimming Bur Versus Conventional Scalpel Technique in Ginigival Depigmentation Procedure N/A
Recruiting NCT04765930 - Combined Q-switched Nd:YAG Laser and Platelet Rich Plasma Versus Q- Switched Nd:YAG Laser Alone in Melasma N/A
Active, not recruiting NCT05493280 - Fractionated 1927nm Laser for Hyperpigmentation in Fitzpatrick Skin Phototypes V and VI N/A
Recruiting NCT06253455 - Efficacy and Tolerability of the Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 Origins N/A
Not yet recruiting NCT06080035 - The Effects of Cetyl Tranexamate Mesylate on the Appearance of Acne-Related Hyperpigmentation N/A
Completed NCT03457246 - Efficacy and Tolerance of D-pigment Versus Moisturizer in Hands' Lentigo Lesions With or Without Laser Therapy N/A
Completed NCT04619589 - Characterization of Dyschromic Hypertrophic Scar
Recruiting NCT05165524 - Brightening Cream and Lasers in Post-sclerotherapy Hyperpigmentation N/A
Not yet recruiting NCT06268496 - Efficacy and Tolerability of the Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 Origins N/A
Not yet recruiting NCT06253468 - Efficacy and Tolerability of Tested Formula After 3 Months of Treatment of Facial Hyperpigmentation of 3 Origins N/A
Completed NCT05423873 - A Multi-Center, Open-label Study Evaluate the Efficacy and Tolerability of a Dual Skincare Regimen Treatment for Facial Hyperpigmentation and Photodamaged Skin in Patients Exposed to Extrinsic Factors of Aging N/A
Completed NCT01149876 - Study to Evaluate the Effect of a Nu Skin Product and Device for Brown Spots Phase 4
Completed NCT01542138 - Clinical Trial of 4% Niacinamide Versus 0.05% Desonide for the Treatment of Axillar Hyperpigmentation Phase 4
Completed NCT06189768 - A Study on Pigmentation Disorders in Children
Completed NCT06103461 - Fat Grafting an Ideal Filler For Contour Deformities With Hyperpigmentation On Face N/A
Not yet recruiting NCT06234527 - Efficacy and Tolerability of the Tested Formula After 3 Months of Treatment of Facial Hyperpigmentation of 3 Origins N/A